Drugs / ProAir® Digihaler™
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | PROAIR RESPICLICK | — | 2016-04-28 | fda.gov ↗ |
| Approved | US (FDA) | PROAIR RESPICLICK | — | 2015-03-31 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04997304 Background | Jul 2021 → Dec 2023 | asthma | University of Michigan | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProAir Digihaler | “Participants will receive the ProAir® Digihaler™ 90mcg at a dose that is equivalent to the participants' current inhaled therapy dose.” NCT04997304 ↗ |